Older women with a very early, non-invasive breast cancer known as ductal carcinoma in situ (DCIS) gain no long-term benefit from undergoing a sentinel lymph node biopsy to see if the cancer has ...

Neck lymph node status is the most important factor for prognosis in head and neck squamous cell carcinoma. Sentinel node detection reliably predicts the lymph node status in melanoma and breast ...

A total of 751 women clinically node negative post-NACT underwent LAS (excision of lymph node [LN] and fat below first intercostobrachial nerve). Of these women, 730 also underwent SNB by dual ...

New recommendations regarding the use of sentinel lymph node biopsy in patients with early stage breast cancer were issued by The American Society of Clinical Oncology (ASCO) and published in the ...

One of the most important incremental steps in breast cancer has been to lessen the amount of axillary surgery that is needed to stage breast cancer. Sentinel node biopsy appears to lead a much lower ...

The sentinel node is the first lymph node that filters lymphatic fluid from the tissue surrounding a tumor. As the first node in the lymph circulatory system “downstream” from the tumor, this is more ...

The recent publication of the results of the American College of Surgeons Oncology Group trial Z0011 has generated substantial interest in the medical community and public press. 1,2 This trial ...

Please provide your email address to receive an email when new articles are posted on . Similar proportions of older women with node-negative and node-positive early breast cancer had Oncotype Dx ...

Lymph node status in stage I hormone receptor-positive/HER2-negative breast cancer was not a good indicator of genetic-risk scores that would qualify older women for ...

Please provide your email address to receive an email when new articles are posted on . Sentinel lymph node biopsy (SLNB) is a low-risk procedure that can reduce the need for complete lymph node ...

A recent prospective study sought to identify the subgroup of melanoma patients (based on age and tumor thickness) in which the risk of nodal metastasis is low and who may avoid routine SLN biopsy.